Updated Quality Measures Released July 28

The CoC NCDB RCRS has released updates of three Quality Measures:

• Breast BCSRT: Radiation therapy, when administered, is initiated less than or equal to 60 days of definitive surgery for patients receiving breast conserving surgery for Stage I-III breast cancer who do not undergo adjuvant chemo- or immuno-therapy.
• Gastric G16RLN: At least 16 regional lymph nodes are removed and pathologically examined for patients with surgically resected gastric adenocarcinoma undergoing curative intent therapy.
• Lung LCT: Systemic chemotherapy, immunotherapy or targeted therapy is administered or recommended within 3 months preoperatively or 3 months postoperatively for surgically resected cases with pathologic T2 greater than 4cm or T greater than or equal to 3, or N greater than or equal to 1 Non-Small Cell Lung Cancer (NSCLC).

As a result of the clinical modifications made to the measure eligibility and numerator criteria, programs may notice changes to their estimated performance rates.

All measure specifications, including the case eligibility and numerator criteria, have been posted to the RCRS Library. If you have questions regarding the new quality measure, please post a question to the CAnswer Forum. For program specific questions contact ncdb@facs.org.